Related Experiment Video
Updated: Jan 4, 2026

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy
John R Edminister1, Nicole Dominiak2, Lorie D Gottwald3
1University of Toledo College of Medicine and Life Sciences, 3000 Arlington Avenue, Toledo, OH 43614, USA.
Livedoid vasculopathy patients on corticosteroids may develop rare skin infections. Early diagnosis of atypical mycobacterial infection is crucial for effective treatment.
Area of Science:
- Dermatology
- Infectious Diseases
- Microbiology
Background:
- Livedoid vasculopathy (LV) is a rare condition lacking definitive treatment, often managed with corticosteroids.
- Corticosteroids, while alleviating LV pain, carry risks like immunosuppression.
- Diabetes mellitus is a common comorbidity in patients with chronic inflammatory conditions.
Observation:
- A case of disseminated cutaneous infection caused by Mycobacterium chelonae/abscessus is presented.
- The infection occurred in a diabetic patient with a history of long-term corticosteroid use.
- The patient presented with a diffuse onset of ulcerative skin nodules.
Findings:
- The patient required an intensive antibiotic regimen for the disseminated cutaneous infection.
- Potential lifelong antibiotic suppression may be necessary pending infection improvement.
- Rapidly growing mycobacterial (RGM) infections should be considered in immunocompromised patients with specific skin manifestations.
Implications:
- This case highlights the importance of considering atypical mycobacterial infections in patients with risk factors like diabetes and corticosteroid use.
- Increased awareness can lead to earlier diagnosis and appropriate management of these rare but serious infections.
- Further research into the interplay between immunosuppression, diabetes, and mycobacterial skin infections is warranted.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

